Revenue | ₹16,099.38Cr |
Net Profits | ₹3,368.81Cr |
Net Profit Margins | 20.93% |
Sun Pharmaceutical Industries Ltd’s revenue jumped 13.85% since last year same period to ₹16,099.38Cr in the Q3 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 7.7% jump in its revenue since last 3-months.
Sun Pharmaceutical Industries Ltd’s net profit jumped 16.03% since last year same period to ₹3,368.81Cr in the Q3 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 8.05% jump in its net profits since last 3-months.
Sun Pharmaceutical Industries Ltd’s net profit margin jumped 1.92% since last year same period to 20.93% in the Q3 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 0.32% jumped in its net profit margins since last 3-months.
The revenue for Sun Pharmaceutical Industries Ltd in the Q3 results 2025 was ₹16,099.38Cr.
The net profit for Sun Pharmaceutical Industries Ltd in the Q3 results 2025 was ₹3,368.81Cr.
The net profit margin for Sun Pharmaceutical Industries Ltd in the Q3 results 2025 was 20.93%.
The revenue for Sun Pharmaceutical Industries Ltd in the Q3 results 2024 was ₹14,141.08Cr.
The net profit for Sun Pharmaceutical Industries Ltd in the Q3 results 2024 was ₹2,903.38Cr.
The net profit margin for Sun Pharmaceutical Industries Ltd in the Q3 results 2024 was 20.53%.